The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter phase 2 study of nintedanib in patients (pts) with advanced progressing carcinoid tumors.
 
Renuka V. Iyer
Honoraria - Ipsen
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Eisai; Eisai; Ipsen; Lexicon; Merck; Merck; Novartis; Novartis
Research Funding - Cleveland BioLabs (Inst); Genentech/Roche (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Bhavana Konda
No Relationships to Disclose
 
Dwight Hall Owen
Consulting or Advisory Role - L&M Policy Research
 
Kristopher Attwood
No Relationships to Disclose
 
Suman Sarker
No Relationships to Disclose
 
Sheryl-Ann Suffren
No Relationships to Disclose
 
John Wilton
No Relationships to Disclose
 
Robert Bies
No Relationships to Disclose
 
Danielle Casucci
No Relationships to Disclose
 
Diane Lauren Reidy
Honoraria - Novartis
Consulting or Advisory Role - Ipsen; Novartis; Pfizer
Research Funding - Novartis
 
Manisha H. Shah
Consulting or Advisory Role - Eisai; Loxo; Novartis
Research Funding - Eisai; Loxo; Merck